Comparison of brain atrophy in patients with multiple sclerosis treated with first- versus second-generation disease modifying therapy without clinical relapse.,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Comparison of brain atrophy in patients with multiple sclerosis treated with first- versus second-generation disease modifying therapy without clinical relapse.
European Journal of Neurology ( IF 4.5 ) Pub Date : 2020-05-19 , DOI: 10.1111/ene.14335
H Masuda ₁ , M Mori ₁ , S Hirano ₁ , A Uzawa ₁ , T Uchida ₁ , R Ohtani ₁ , R Aoki ₁ , S Kuwabara ₁

Affiliation

The silent progression of patients with multiple sclerosis (MS) has been reported. The aim of this study was to investigate the association between brain atrophy rates and disease‐modifying drugs (DMDs) in patients with MS during their relapse‐free period.

中文翻译：